The effects of overexpression and knockdown of WDR76 on decrement and increment of RAS protein levels, respectively, were verified in cancer cells including RAS-mutated cancer cells, indicating that WDR76 degrades RAS proteins regardless of their mutational status. Here, WDR76 is linked to cancer.